BioCentury
ARTICLE | Clinical News

ALZT-OP1: Phase III started

September 28, 2015 7:00 AM UTC

AZTherapies began the double-blind, placebo-controlled, international Phase III trial to compare ALZT-OP1 vs. each of its components -- inhaled cromolyn and oral ibuprofen -- in about 600 patients. Th...